Gaining entry to Retatrutide, the new medication for obesity treatment , currently presents a challenge for many. As of now , it isn't widely available in most countries. Limited clinical studies and a restricted rollout are contributing to this situation. People interested in using Retatrutide should consult their physician to assess suitability a